Broncus Holding Corporation (HKG:2216)
Hong Kong · Delayed Price · Currency is HKD 2.280
-0.020 (-0.87%)
At close: Jan 21, 2026
Broncus Holding Market Cap
Broncus Holding has a market cap or net worth of 1.2 billion as of January 21, 2026. Its market cap has increased by 279.55% in one year.
Market Cap
1.20B
Enterprise Value
176.39M
Revenue
47.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.28
Market Cap Chart
Since September 24, 2021, Broncus Holding's market cap has decreased from 7.88B to 1.20B, a decrease of -84.77%. That is a compound annual growth rate of -35.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 1.21B | -3.36% |
| Dec 31, 2025 | 1.25B | 302.92% |
| Dec 31, 2024 | 311.05M | -25.32% |
| Dec 29, 2023 | 416.49M | -65.47% |
| Dec 30, 2022 | 1.21B | -74.55% |
| Dec 31, 2021 | 4.74B | -39.89% |
| Sep 24, 2021 | 7.88B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.88B |
| Hansoh Pharmaceutical Group Company | 260.32B |
| JD Health International | 212.13B |
| WuXi Biologics | 156.50B |
| Innovent Biologics | 148.05B |
| Sino Biopharmaceutical | 124.24B |
| CSPC Pharmaceutical Group | 112.39B |
| Akeso | 111.46B |